Targeting the EGFR T790M mutation in non-small-cell lung cancer-Reference-Cited by-同舟云学术

Targeting the EGFR T790M mutation in non-small-cell lung cancer

Published:2016-12-23 Issue:2 Volume:21 Page:159-165
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Normanno Nicola¹,Maiello Monica Rosaria¹,Chicchinelli Nicoletta¹,Iannaccone Alessia²,Esposito Claudia²,De Cecio Rossella³,D’alessio Amelia¹,De Luca Antonella¹

Affiliation:

1. Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori ‘Fondazione G. Pascale’-IRCCS, Naples, Italy

2. Laboratory of Pharmacogenomics, CROM-Istituto Nazionale Tumori ‘Fondazione G. Pascale’-IRCCS, Naples, Italy

3. Surgical Pathology Unit, Istituto Nazionale Tumori ‘Fondazione G. Pascale’-IRCCS, Naples, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2017.1272582

Reference62 articles.

1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

3. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

4. Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?

5. Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel quinazoline-based dual EGFR/c-Met inhibitors overcoming drug resistance for the treatment of NSCLC: Design, synthesis and anti-tumor activity;Bioorganic Chemistry;2024-01

2. Characterization of circRNAs in established osimertinib‑resistant non‑small cell lung cancer cell lines;International Journal of Molecular Medicine;2023-09-07

3. EGFR-T790M Mutation–Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer;Molecular & Cellular Proteomics;2023-09

4. Liquid biopsies, are we ready for prime time?;Journal for ImmunoTherapy of Cancer;2023-02

5. Molecular Carcinogenesis of Lung Cancer;Airway diseases;2023